Aspen Aerogels, Inc. $ASPN Shares Bought by Palogic Value Management L.P.

Key Points

• Palogic Value Management L.P. increased its stake in Aspen Aerogels by 226.9% during the first quarter, acquiring an additional 295,000 shares, now holding 425,000 shares total.
• The company's stock has a 52-week low of $4.16 and a high of $30.24, with current trading around $6.83 and a market capitalization of $562.52 million.
• Aspen Aerogels reported a revenue of $78.02 million for the last quarter, exceeding analysts' expectations, but faced a 33.8% decline year-over-year compared to the previous quarter.

Palogic Value Management L.P. raised its position in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 226.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 425,000 shares of the construction company's stock after buying an additional 295,000 shares during the period. Aspen Aerogels makes up about 1.2% of Palogic Value Management L.P.'s holdings, making the stock its 29th biggest holding. Palogic Value Management L.P. owned approximately 0.52% of Aspen Aerogels worth $2,716,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Trexquant Investment LP boosted its position in Aspen Aerogels by 114.7% in the 1st quarter. Trexquant Investment LP now owns 860,246 shares of the construction company's stock valued at $5,497,000 after buying an additional 459,582 shares during the last quarter. Eisler Capital Management Ltd. bought a new position in shares of Aspen Aerogels during the first quarter worth about $99,000. FORA Capital LLC bought a new position in shares of Aspen Aerogels during the first quarter worth about $79,000. MetLife Investment Management LLC lifted its position in shares of Aspen Aerogels by 2,036.3% during the first quarter. MetLife Investment Management LLC now owns 764,423 shares of the construction company's stock worth $4,885,000 after purchasing an additional 728,641 shares during the last quarter. Finally, Penn Capital Management Company LLC bought a new position in shares of Aspen Aerogels during the first quarter worth about $4,107,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total transaction of $32,237.10. Following the sale, the chief accounting officer owned 19,879 shares in the company, valued at $145,315.49. This represents a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 3.40% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on ASPN shares. Barclays cut shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and increased their price target for the stock from $7.00 to $16.00 in a research report on Monday, August 11th. Canaccord Genuity Group reduced their price target on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. Finally, Oppenheimer cut shares of Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, Aspen Aerogels presently has a consensus rating of "Moderate Buy" and a consensus target price of $19.50.

Aspen Aerogels Stock Performance

ASPN traded down $0.13 on Monday, hitting $6.83. 1,079,251 shares of the company's stock were exchanged, compared to its average volume of 2,428,220. The firm has a market cap of $562.52 million, a PE ratio of -1.79 and a beta of 2.65. Aspen Aerogels, Inc. has a twelve month low of $4.16 and a twelve month high of $30.24. The stock has a fifty day moving average of $7.03 and a two-hundred day moving average of $6.56. The company has a current ratio of 3.98, a quick ratio of 3.31 and a debt-to-equity ratio of 0.34.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.08. The firm had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. Aspen Aerogels's quarterly revenue was down 33.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. On average, research analysts anticipate that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.